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Objective: Dose adjustment for induction of ovulation is one of the most important 
problem. Methods: In a prospective interventional study, 44 clomiphene-resistant 
infertile patients (113 cycles) were selected from the Abolfazl Infertility Clinic of 
Bushehr University of Medical Sciences. Letrozole was given orally in a dose of 2.5 
mg, 5 mg, and 7.5mg, respectively. If the patient displayed no response, the dosage was 
increased. 
Results: In these patients ovulation occurred in 50 cycles (44.24%), clinical pregnancy 
rate according to number of cycles was 23.89% (27 of 113 cycles) and according to the 
number of patients was 61.36% (27 of 44 patients). In the 2.5, 5, and 7.5 groups, 
follicles occurred in 22.9%, 42.1%, and 85.18% of cycles, and pregnancy rate was 
14.58%, 28.94% and, 33.33%, respectively. 
Conclusions: It is better to administer Letrozole at a lower dosage to prevent 
complications and increase the dose based on sonographic results antral follicular count, 
anti-Mullerian hormone, LH/FSH, and estradiol. 
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Introduction 
 
Infertility 
Infertility is a common condition with important psychologic, economic, 
demographic, and medical implications. Demand for infertility services has grown 
substantially even though the prevalence of infertility has been stable. This 
phenomenon may be due to entry of the "baby boom" generation into the 
reproductive age group during a period of highly publicized technologic advances, 
and unparalleled publicity given to fertility issues in the lay press. 
Infertility is a unique medical condition because it involves a couple, rather than a 
single individual. It is defined as failure of a couple to conceive after 12 months of 
regular intercourse without use of contraception in women less than 35 years of 
age; and after six months of regular intercourse without use of contraception in 
women 35 years and older [1]. Some clinicians use the term subfertility to describe 
this failure to conceive unless the couple has been proven to be sterile. 
Fecundability, the probability of achieving a pregnancy in one menstrual cycle, is a 
more accurate descriptor because it recognizes varying degrees of infertility. 
Normal Fertility: The concept of fecundability has proven useful for establishing 
normal parameters in studies of fertility potential: 
• A study examined the number of months to conception in 5574 normal 
women who had unprotected intercourse and who became pregnant between 
1946 and 1956 [2]. Eighty-five percent of the women conceived within 12 
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months. Fecundability was 0.25 in the first three months of observation, and 
then decreased to 0.15 during the next nine months of observation. 
• Another study of 200 healthy couples who desired pregnancy also noted that 
fecundability declined from 0.25 in the first three months to 0.11 in the next 
nine months of observation [3]. Eighty-two percent of the couples conceived 
within 12 months. 
• A study conducted in China reported that 518 newly married textile workers 
aged 20 to 34 years who intended to conceive did so at a rate of about 50 
percent within two cycles and 88 percent within six months [4]. Monthly 
fecundity ranged from 0.30 to 0.35. 
• A large prospective European study investigated 346 users of natural family 
planning methods who were trying to achieve conception [5]. The estimated 
cumulative probabilities of conception for the total group at 1, 3, 6, and 12 
months were 38, 68, 81, and 92 percent, respectively. The authors postulated 
that after six months, 50 percent of the remaining couples were subfertile or 
infertile. 
While these studies demonstrate that the large majority (80 to 90 percent) of 
apparently normal couples will conceive within the first year of attempted 
conception, they also show that the fecundability of the cohort decreases over time 
and with increasing age of the female partner. Thus, the possibility of infertility 
may be suspected after only six months of unprotected intercourse without 
conception. Patients who have not achieved pregnancy after 12 months have even 
lower fecundability. Five to 15 percent of apparently normal couples will conceive 
in the second 12 months of attempted conception so that after 24 months of trying 
to become pregnant, 95 percent of couples will have conceived. 
 4 
Several authorities have proposed a system of prognostic grading in conjunction 
with statements describing the couple's fertility history and diagnosis in order to 
reduce confusing terminology and to facilitate an appropriate treatment plan [6]. 
This system has not yet been widely accepted. In general, women who are under 
age 30, who have a less than two-year history of infertility, who have had a 
previous pregnancy, and who do not have tubal disease, anovulation, partners with 
male factor infertility, or endometriosis, have the best prognosis for treatment-
independent conception [7]. 
Prevalence of infertility: The National Survey of Family Growth interviewed 
15,303 married women aged 15 to 44 to estimate the prevalence of infertility in the 
United States [8]. Married women were considered infertile if they reported they 
had not conceived over the past 12 months and were sexually active and not using 
contraception or surgically sterilized [8]. From 1982 to 2002, the percentage of 
married women meeting these criteria for infertility fell from 8.5 to 7.4 percent. 
In contrast, the estimated percent of married women with impaired fecundity 
increased from 11 percent in 1982 to 15 percent in 2002 [9]. Impaired fecundity 
was defined as a 36-month interval of unprotected sexual activity without 
conception or the woman's perception that it was physically impossible or difficult 
for her to conceive or her husband to father a child (does not include surgically 
sterile individuals). 
The reasons for these discordant trends cannot be fully explained. However, it is 
clear that many women seek medical advice and intervention to help them become 
pregnant. The National Survey of Family Growth reported that 1.2 million women 
(2 percent of reproductive aged women) had one or more visits with a health care 
provider for this indication in 2002 and 10 percent had received infertility services 
at some time in their lives [9]. 
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Race and ethnicity: It is not known whether fecundity varies among racial and 
ethnic groups when adjusted for confounders. 
The National Survey of Family Growth found that married black women had about 
twice the odds of infertility as married white women, after adjustment for 
education, income, and self-reported history of pelvic inflammatory disease [8]. 
Others have shown that this disparity cannot be explained by differences in 
common risk factors for infertility, such as smoking, obesity, fibroids, or ovarian 
volume [10]. 
This report also noted that the proportion of US Hispanic women reporting 
infertility has remained stable and white women have experienced a decline. There 
are no data on US Asian women. 
Causes of infertility: The World Health Organization (WHO) task force on 
Diagnosis and Treatment of Infertility performed a study of 8500 infertile couples 
and utilized standard diagnostic criteria to determine the medical conditions 
contributing to infertility [11]. In developed countries, female factor infertility was 
reported in 37 percent of infertile couples, male factor infertility in 8 percent, and 
both male and female factor infertility in 35 percent. Five percent of couples had 
unexplained infertility and 15 percent became pregnant during the study. This 
study illustrates that infertility should not be assumed to result primarily from 
disorders in the female partner. 
Some causes of infertility are easily identifiable, such as azoospermia (no sperm 
cells in the ejaculate), longstanding amenorrhea, or bilateral tubal obstruction. 
However, the situation is less clear in most couples: the sperm may be reduced in 
number, but are not absent; there may be oligomenorrhea with some ovulatory 
cycles; the woman may have partial tubal obstruction; or a menstrual history may 
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suggest intermittent ovulation. It is often difficult to weigh or prioritize these 
findings when counseling infertile couples or planning treatment programs. 
Adding to the complexity of the situation, there are few data regarding the 
predictive validity of these tests despite their widespread use. Thus, short of the 
absolute infertility factors mentioned (eg, azoospermia or bilateral tubal 
obstruction), an abnormal test result cannot be said to be the cause of infertility in a 
particular couple. 
The uncertain causal relationship between an abnormality on infertility testing and 
the actual cause of infertility makes it difficult to estimate the relative frequency of 
the causes of infertility. Nevertheless, it is instructive to estimate the frequency 
with which various factors are found in association with infertility as a rough proxy 
for their relative importance. One population-based study reported the following 
results [12]: 
• Male factor (hypogonadism, post-testicular defects, seminiferous tubule 
dysfunction) — 26 percent 
• Ovulatory dysfunction — 21 percent 
• Tubal damage — 14 percent 
• Endometriosis — 6 percent 
• Coital problems — 6 percent 
• Cervical factor — 3 percent 
• Unexplained — 28 percent 
The frequency of these factors in infertility is similar whether infertility is primary 
or secondary, and has not changed significantly over the past 25 years in developed 
countries [13]. 
